Vertex Pharmaceuticals Inc (VRTX)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 9,596,400 | 14,144,200 | 13,234,800 | 9,560,600 | 8,133,400 |
| Total current liabilities | US$ in thousands | 3,564,600 | 3,547,400 | 2,742,100 | 2,142,000 | 1,877,500 |
| Current ratio | 2.69 | 3.99 | 4.83 | 4.46 | 4.33 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $9,596,400K ÷ $3,564,600K
= 2.69
The current ratio of Vertex Pharmaceuticals Inc has shown a generally increasing trend over the past five years, starting at 4.33 in 2020 and rising to a peak of 4.83 in 2022. However, in 2023, the current ratio decreased to 3.99, which may indicate a slight weakening in the company's short-term liquidity position. The ratio further dropped to 2.69 in 2024, suggesting a significant decrease in the company's ability to cover its short-term obligations with its current assets. As a result, it is important for stakeholders to monitor Vertex Pharmaceuticals Inc's liquidity closely in the coming periods to assess any potential impact on its financial health.
Peer comparison
Dec 31, 2024